Introduction The use of noninvasive and invasive diagnostic tests improves the accuracy of
mediastinal staging for lung cancer. It is unknown how frequently multimodality mediastinal …

Objective Prior studies have reported underuse of—but not variability in—invasive
mediastinal staging in the pretreatment evaluation of patients with lung cancer. We sought to …

Introduction Guidelines recommend that patients with clinical stage IIIA non-small cell lung
cancer (NSCLC) undergo histologic confirmation of pathologic lymph nodes. Studies have …

Background Prior studies suggest underutilization of invasive mediastinal staging for lung
cancer. We hypothesized that The Society of Thoracic Surgeons General Thoracic Surgery …

Background Guidelines recommend invasive mediastinal staging for patients with non-small
cell lung cancer and a “central” tumor. However, there is no consensus definition for central …

Accurate mediastinal staging is important, and many imaging and invasive mediastinal
staging tests are available. The data are confusing because patients with particular …

Background We characterized the performance characteristics of guideline-recommended
invasive mediastinal staging (IMS) for lung cancer and developed a prediction model for …

Background Correct mediastinal staging is a cornerstone in the treatment of patients with
non-small cell lung cancer. A large range of methods is available for this purpose, making …

Background The treatment of non-small cell lung cancer (NSCLC) is determined by accurate
definition of the stage. If there are no distant metastases, the status of the mediastinal lymph …

The pulmonologist is the focal point for the diagnosis and staging of lung cancer. Accurate
staging is imperative because of the implications that stage has on different treatment …